Pfam Domains GO Terms
| UPF0004 |
| TRAM |
| Radical SAM |
| N6-isopentenyladenosine methylthiotransferase activity |
| tRNA methylthiolation |
| positive regulation of translational fidelity |
| mitochondrial tRNA modification |
| mitochondrial RNA modification |
| mitochondrial tRNA processing |
| tRNA threonylcarbamoyladenosine metabolic process |
| mitochondrial RNA processing |
| positive regulation of mitochondrial translation |
| regulation of translational fidelity |
| regulation of mitochondrial translation |
| regulation of mitochondrial gene expression |
| negative regulation of cyclin-dependent protein serine/threonine kinase activity |
| negative regulation of cyclin-dependent protein kinase activity |
| mitochondrial RNA metabolic process |
| 4 iron, 4 sulfur cluster binding |
| tRNA modification |
| regulation of cyclin-dependent protein serine/threonine kinase activity |
| regulation of cyclin-dependent protein kinase activity |
| positive regulation of translation |
| tRNA processing |
| negative regulation of protein serine/threonine kinase activity |
| mitochondrial gene expression |
| positive regulation of cellular amide metabolic process |
| RNA modification |
| tRNA metabolic process |
| negative regulation of protein kinase activity |
| negative regulation of kinase activity |
| protein-containing complex binding |
| negative regulation of transferase activity |
| regulation of translation |
| ncRNA processing |
| regulation of cellular amide metabolic process |
| negative regulation of protein phosphorylation |
| negative regulation of phosphorylation |
| cellular component |
| protein kinase binding |
| ncRNA metabolic process |
| regulation of protein serine/threonine kinase activity |
| posttranscriptional regulation of gene expression |
| negative regulation of phosphate metabolic process |
| negative regulation of phosphorus metabolic process |
| negative regulation of cell cycle |
| negative regulation of protein modification process |
| regulation of neuron differentiation |
| brain development |
| head development |
| negative regulation of catalytic activity |
| regulation of protein kinase activity |
| regulation of neurogenesis |
| regulation of kinase activity |
| RNA processing |
| regulation of nervous system development |
| regulation of cell development |
| regulation of transferase activity |
| central nervous system development |
| negative regulation of cellular protein metabolic process |
| negative regulation of protein metabolic process |
| negative regulation of molecular function |
| regulation of cell cycle |
| mitochondrion |
| regulation of protein phosphorylation |
| generation of neurons |
| regulation of phosphorylation |
| positive regulation of cellular protein metabolic process |
| neurogenesis |
| RNA metabolic process |
| positive regulation of protein metabolic process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of cell differentiation |
| regulation of protein modification process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution